Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 15/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | SYK | P43405 | 2/20 | 0.44 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5790407 | 0.93 | CNR2 (0.72) | CNR2CYP1A2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL5786302 | 0.93 | CNR2 (0.64) | CNR2CYP1A2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL5790174 | 0.90 | CNR2 (0.62) | CNR2CYP1A2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL5791832 | 0.90 | CNR2 (0.73) | CNR2CYP1A2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL5791800 | 0.85 | CNR2 (0.56) | CNR2CYP1A2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL5788577 | 0.85 | CNR2 (0.61) | CNR2CYP1A2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL5791466 | 0.85 | CNR2 (0.73) | CNR2CYP1A2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL5791451 | 0.85 | CNR2 (0.62) | CNR2CYP1A2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL5792571 | 0.83 | CNR2 (0.72) | CNR2CYP1A2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL5790689 | 0.83 | CNR2 (0.72) | CNR2CYP1A2CYP2C9CYP2C19CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1534687-B1 | 2-PHENYLAMINO-4-TRIFLUOROMETHYL-5-(BENZYL- OR PYRIDIN-4-YLMETHYL)CARBAMOYLPYRIMIDINE DERIVATIVES AS SELECTIVE CB2 CANNABINOID RECEPTOR MODULATORS | GLAXO GROUP LTD (GB) | 2006-09-27 | — | — | EP | claimed |